6 Best Biosimilar Startups to Watch in 2025

The Definitive Seedtable Ranking of Biosimilar Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 6 start-ups with an aggregate funding of $553.4m. The average funding per company in this subset is $92.2m.

Last update to the database: Feb 18, 2025. See changelog.

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up
Antheia logo

Antheia

Antheia is an American biotechnology company founded in 2013, and is located in Menlo Park, California. Antheia uses synthetic biology, informatics, and fermentation technologies to produce plant based medicines; most notably opioids using yeast.

1

Funding Rounds

$73.0m

Money raised

Alvotech logo

Alvotech

Alvotech is a Reykjavík-based company founded in 2013.

1

Funding Rounds

$300.0m

Money raised

Panacea Biotec logo

Panacea Biotec

Panacea Biotec is a differentiated generics, vaccines, biosimilars founded in 1994 by Soshil Kumar Jain.

1

Funding Rounds

$144.0m

Money raised

Askgene Pharma logo

Askgene Pharma

Askgene Pharma is a company founded in 2012.

1

Funding Rounds

$20.0m

Money raised

Nanolek logo

Nanolek

Nanolek is a biosimilars, Vaccines, Contract Manufacturing.

1

Funding Rounds

Aprogen logo

Aprogen

Antibodies, biosimilars, generics

1

Funding Rounds

$16.4m

Money raised